12/11/2014 - 7:47pm

Clinicians are more open to utilizing burgeoning healthcare technology as part of their practice, and patients are more receptive to interacting with that technology, according to a new PricewaterhouseCoopers Health Research Institute report released last month titled “Healthcare delivery of the future: How digital technology can bridge the gap of time and distance between clinicians and consumers.”

 
11/17/2014 - 7:48pm

Pepsi has entered the artisanal beverage space with Caleb’s Kola, a drink made with cane sugar, kola nut extract and a blend of spices packaged in 10-oz. glass bottles. Each bottle has 110 calories and 29 grams of sugar.

11/17/2014 - 7:48pm

In response to the growing popularity of soft drinks sweetened with cane sugar and the spike in demand for “MexiCoke,” Coke has started distributing the product itself in the United States.

11/17/2014 - 7:48pm

It’s a new era for carbonated beverages. Sales have been falling for a decade as consumers have shifted away from traditional sodas sweetened with high-fructose corn syrup and are avoiding diet sodas due to concerns about artificial sweeteners.

11/17/2014 - 7:46pm

mHealth — the use of mobile technology devices and smartphones for healthcare purposes — is transforming health care as more Americans adopt mobile devices. 

11/17/2014 - 7:46pm

Last year, Drug Store News covered extensively the results from Thrifty White's successful medication synchronization program. DSN recently checked in with Tim Weippert, Thrifty White EVP pharmacy, to get an update.

 
11/17/2014 - 7:46pm

Drug Store News caught up with Upsher-Smith chief commercial officer Rusty Field to discuss topiramate extended-release capsules, its new authorized generic to Qudexy XR.

11/17/2014 - 7:45pm

DSN spoke with Neas in late October to mark the 30th anniversary of the landmark Drug Price Competition and Patent Term Restoration Act — better known as the Hatch-Waxman Act. 

11/17/2014 - 7:45pm

Thirty years ago, Democratic and Republican members of Congress hammered out a rare and prescient bipartisan compromise bill that transformed the pharmaceutical landscape forever and unleashed the modern generic drug industry. That law, known as the Hatch-Waxman Act, has proven to be one of the most far-reaching and impactful pieces of legislation ever to shape the American healthcare system.